AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug
- PMID: 23851909
- DOI: 10.1097/FTD.0b013e31828b2a50
AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug
Abstract
Objectives: To compare and contrast the pharmacokinetic/pharmacodynamic foundations of traditional "peak-trough" vancomycin dosing methods versus newer "area under the curve" (AUC) strategies. To propose a new AUC-based dosing chart for empirically determining an initial vancomycin dosing regimen designed to achieve a desired AUC24 using the minimum inhibitory concentration (MIC), creatinine clearance (CrCl), and vancomycin clearance (ClVanco).
Review of vancomycin dosing: Peak-trough vancomycin dosing is designed to achieve a Cpeak of 20-40 mg/L and a Ctrough of 10-15 or 15-20 mg/L, depending on the severity of the infection and the nature of the pathogen. New treatment guidelines for vancomycin suggest that therapy should achieve an AUC24/MIC of ≥400. AUC-based vancomycin dosing derives the daily dose from ClVanco, MIC, and the desired AUC24/MIC, without consideration of the patient's weight.
New auc dosing chart: A vancomycin dosing chart is proposed that estimates ClVanco using the following formula developed by Matzke et al: ClVanco in L/h = [(CrClmL/min × 0.689) + 3.66] × 0.06, which simplifies to (CrClmL/min × 0.41) + 0.22. Two levels of dosing are included-high dose (Ctrough: 15-20 mg/L) and moderate dose (Ctrough: 10-15 mg/L). Although the chart has not been validated clinically, it represents the product of standard dosing equations that are used to determine a starting dosing regimen based on well-established vancomycin pharmacokinetic parameters.
Conclusions: An understanding of pharmacokinetic and pharmacodynamic principles, including the relevance of AUC in relation to MIC, enables clinicians to make the best use of vancomycin dosing options. The proposed dosing chart is pharmacokinetically valid but has yet to be applied clinically. It provides a foundation for further study of how clinicians can determine an optimal AUC-based starting vancomycin dosing regimen without having to derive ClVanco or AUC24.
Similar articles
-
The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.J Clin Pharm Ther. 2015 Jun;40(3):259-65. doi: 10.1111/jcpt.12270. Epub 2015 Apr 11. J Clin Pharm Ther. 2015. PMID: 25865426 Review.
-
Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.J Clin Pharm Ther. 2016 Aug;41(4):399-402. doi: 10.1111/jcpt.12399. Epub 2016 May 4. J Clin Pharm Ther. 2016. PMID: 27144370
-
Vancomycin dosing in children and young adults: back to the drawing board.Pharmacotherapy. 2013 Dec;33(12):1278-87. doi: 10.1002/phar.1345. Epub 2013 Sep 9. Pharmacotherapy. 2013. PMID: 24019205
-
Correlation of the vancomycin 24-h area under the concentration-time curve (AUC24) and trough serum concentration in children with severe infection: A clinical pharmacokinetic study.Int J Infect Dis. 2020 Mar;92:151-159. doi: 10.1016/j.ijid.2019.12.036. Epub 2020 Jan 11. Int J Infect Dis. 2020. PMID: 31935538
-
Vancomycin dosing in children: what is the question?Arch Dis Child. 2013 Dec;98(12):994-7. doi: 10.1136/archdischild-2013-304169. Epub 2013 Aug 16. Arch Dis Child. 2013. PMID: 23956256 Review.
Cited by
-
Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.Eur Radiol. 2019 Dec;29(12):6982-6990. doi: 10.1007/s00330-019-06321-6. Epub 2019 Jul 1. Eur Radiol. 2019. PMID: 31264013
-
Navigating Vancomycin and Acute Kidney Injury: AUC- vs. Trough-Guided Monitoring in Initial and Steady-State Therapy.Antibiotics (Basel). 2025 Apr 27;14(5):438. doi: 10.3390/antibiotics14050438. Antibiotics (Basel). 2025. PMID: 40426505 Free PMC article.
-
Population pharmacokinetics and dose optimization of vancomycin in neonates.Sci Rep. 2021 Mar 17;11(1):6168. doi: 10.1038/s41598-021-85529-3. Sci Rep. 2021. PMID: 33731764 Free PMC article.
-
Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes.Pharmacy (Basel). 2016 Nov 10;4(4):37. doi: 10.3390/pharmacy4040037. Pharmacy (Basel). 2016. PMID: 28970410 Free PMC article.
-
Effects of Physiological-Scale Variation in Cations, pH, and Temperature on the Calibration of Electrochemical Aptamer-Based Sensors.ACS Sens. 2024 Dec 27;9(12):6675-6684. doi: 10.1021/acssensors.4c02274. Epub 2024 Nov 21. ACS Sens. 2024. PMID: 39570094 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials